180 related articles for article (PubMed ID: 19798054)
21. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer.
Friedrichs N; Jäger R; Paggen E; Rudlowski C; Merkelbach-Bruse S; Schorle H; Buettner R
Mod Pathol; 2005 Mar; 18(3):431-8. PubMed ID: 15467710
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
[TBL] [Abstract][Full Text] [Related]
24. Functional genomics of AP-2α and AP-2γ in cancers: in silico study.
Kołat D; Kałuzińska Ż; Orzechowska M; Bednarek AK; Płuciennik E
BMC Med Genomics; 2020 Nov; 13(1):174. PubMed ID: 33213447
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma.
Li B; Li A; You Z; Xu J; Zhu S
Cell Death Dis; 2020 Oct; 11(10):823. PubMed ID: 33009370
[TBL] [Abstract][Full Text] [Related]
26. DeltaEF1 promotes breast cancer cell proliferation through down-regulating p21 expression.
Hu F; Wang C; Du J; Sun W; Yan J; Mi D; Zhang J; Qiao Y; Zhu T; Yang S
Biochim Biophys Acta; 2010 Feb; 1802(2):301-12. PubMed ID: 20006705
[TBL] [Abstract][Full Text] [Related]
27. Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.
Zhu CH; Domann FE
Breast Cancer Res Treat; 2002 Jan; 71(1):47-57. PubMed ID: 11859873
[TBL] [Abstract][Full Text] [Related]
28. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
[TBL] [Abstract][Full Text] [Related]
29. Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription.
Li M; Kellems RE
Biol Reprod; 2003 Oct; 69(4):1220-30. PubMed ID: 12801994
[TBL] [Abstract][Full Text] [Related]
30. Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.
Thewes V; Orso F; Jäger R; Eckert D; Schäfer S; Kirfel G; Garbe S; Taverna D; Schorle H
BMC Cancer; 2010 May; 10():192. PubMed ID: 20459791
[TBL] [Abstract][Full Text] [Related]
31. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.
Aqeilan RI; Palamarchuk A; Weigel RJ; Herrero JJ; Pekarsky Y; Croce CM
Cancer Res; 2004 Nov; 64(22):8256-61. PubMed ID: 15548692
[TBL] [Abstract][Full Text] [Related]
32. Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line.
Kotani T; Iwase A; Ino K; Sumigama S; Yamamoto E; Hayakawa H; Nagasaka T; Itakura A; Nomura S; Kikkawa F
Endocrinology; 2009 Sep; 150(9):4376-85. PubMed ID: 19443578
[TBL] [Abstract][Full Text] [Related]
33. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
[TBL] [Abstract][Full Text] [Related]
34. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D
FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366
[TBL] [Abstract][Full Text] [Related]
35. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
Ullmannova V; Popescu NC
Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
[TBL] [Abstract][Full Text] [Related]
37. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
38. The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Kaern J; Flørenes VA; Kopolovic J; Tropé CG; Abeler VM; Reich R; Davidson B
Gynecol Oncol; 2006 Mar; 100(3):462-8. PubMed ID: 16216317
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of AP-2gamma and AP-2alpha during human trophoblast differentiation.
Richardson BD; Cheng YH; Langland RA; Handwerger S
Life Sci; 2001 Sep; 69(18):2157-65. PubMed ID: 11669459
[TBL] [Abstract][Full Text] [Related]
40. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.
Li M; Wang Y; Hung MC; Kannan P
Int J Cancer; 2006 Feb; 118(4):802-11. PubMed ID: 16108032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
